Ozempic is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes treatment, not a vaccine or gene therapy The active ingredient is semaglutide, a 31-amino-acid synthetic peptide produced using yeast cells through recombinant DNA technology Inactive ingredients include standard pharmaceutical excipients: disodium phosphate dihydrate, propylene glycol, phenol, and water for injections The medication is rigorously regulated by the MHRA with a well-characterised safety profile, most commonly causing mild-to-moderate gastrointestinal symptoms Patients should consult healthcare professionals and official sources (NHS.uk, MHRA, Diabetes UK) rather than unverified online information Table of Contents What Is Ozempic and How Does It Work
Stojsavljevi A, Rovanin B, Krsti et al (2019) Evaluation of trace metals in thyroid tissues: comparative analysis with benign and malignant thyroid diseases
Prostate Cancer Prostatic Dis 2006
Retrieved 22 April 2022, from Vitamin B12
Plant secondary metabolites as modulators of mitochondrial health: an overview of their anti-oxidant